Skip to Content

8,441 Results Found

  • Review
  • Open Access
86 Citations
8,119 Views
15 Pages

PAI-1 in Diabetes: Pathophysiology and Role as a Therapeutic Target

  • Rawan Altalhi,
  • Nikoletta Pechlivani and
  • Ramzi A. Ajjan

Hypofibrinolysis is a key abnormality in diabetes and contributes to the adverse vascular outcome in this population. Plasminogen activator inhibitor (PAI)-1 is an important regulator of the fibrinolytic process and levels of this antifibrinolytic pr...

  • Review
  • Open Access
942 Views
32 Pages

PAI-1: A Key Signal at the Crossroads of Stem Cell Differentiation and Senescence

  • Jihan Ke,
  • Youping Jiang,
  • Zhiyong Cheng,
  • Yulan Zhou,
  • Jiaxu Lu,
  • Bo Xu,
  • Shouquan Yan and
  • Jiafeng Wang

Plasminogen activator inhibitor-1 (PAI-1) is a central regulator of the fibrinolytic system and is increasingly recognized for its pivotal roles in a broad spectrum of physiological and pathological processes. In addition to its classical function in...

  • Article
  • Open Access
5 Citations
2,665 Views
11 Pages

HOMA-IR as a Predictor of PAI-1 Levels in Women with Severe Obesity

  • Fabiana Martins Kattah,
  • Milijana Janjusevic,
  • Nayra Figueiredo,
  • Emilly Santos Oliveira,
  • Glaucia Carielo Lima,
  • Ana Raimunda Dâmaso,
  • Lila Missae Oyama,
  • Alessandra Lucia Fluca,
  • Paulo Reis Eselin de Melo and
  • Flávia Campos Corgosinho
  • + 2 authors

Background: Obesity is a chronic inflammatory disorder that increases the risk of cardiovascular diseases (CVDs). Given the high CVD mortality rate among individuals with obesity, early screening should be considered. Plasminogen activator inhibitor...

  • Article
  • Open Access
18 Citations
5,642 Views
14 Pages

Structural Insight into the Two-Step Mechanism of PAI-1 Inhibition by Small Molecule TM5484

  • Machteld Sillen,
  • Toshio Miyata,
  • Douglas E. Vaughan,
  • Sergei V. Strelkov and
  • Paul J. Declerck

2 February 2021

Plasminogen activator inhibitor-1 (PAI-1), a key regulator of the fibrinolytic system, is the main physiological inhibitor of plasminogen activators. By interacting with matrix components, including vitronectin (Vn), PAI-1 plays a regulatory role in...

  • Article
  • Open Access
19 Citations
3,797 Views
16 Pages

PAI-1 Regulation of p53 Expression and Senescence in Type II Alveolar Epithelial Cells

  • Tapasi Rana,
  • Chunsun Jiang,
  • Sami Banerjee,
  • Nengjun Yi,
  • Jaroslaw W. Zmijewski,
  • Gang Liu and
  • Rui-Ming Liu

5 August 2023

Cellular senescence contributes importantly to aging and aging-related diseases, including idiopathic pulmonary fibrosis (IPF). Alveolar epithelial type II (ATII) cells are progenitors of alveolar epithelium, and ATII cell senescence is evident in IP...

  • Article
  • Open Access
15 Citations
4,296 Views
15 Pages

Association between Five Common Plasminogen Activator Inhibitor-1 (PAI-1) Gene Polymorphisms and Colorectal Cancer Susceptibility

  • Jisu Oh,
  • Hui Jeong An,
  • Jung Oh Kim,
  • Hak Hoon Jun,
  • Woo Ram Kim,
  • Eo Jin Kim,
  • Doyeun Oh,
  • Jong Woo Kim and
  • Nam Keun Kim

The plasminogen activator inhibitor-1 (PAI-1) is expressed in many cancer cell types and modulates cancer growth, invasion, and angiogenesis. The present study investigated the association between five PAI-1 gene polymorphisms and colorectal cancer (...

  • Article
  • Open Access
7 Citations
4,592 Views
16 Pages

Association between PAI-1 Polymorphisms and Ischemic Stroke in a South Korean Case-Control Cohort

  • Gun Ho Choi,
  • Sung Hwan Cho,
  • Hui Jeong An,
  • Han Sung Park,
  • Jeong Yong Lee,
  • Eun Ju Ko,
  • Seung Hun Oh,
  • Ok Joon Kim and
  • Nam Keun Kim

Stroke is the second leading cause of death in the world. Approximately 80% of strokes are ischemic in origin. Many risk factors have been linked to stroke, including an increased level of plasminogen activator inhibitor-1 (PAI-1). PAI-1 levels incre...

  • Article
  • Open Access
1,126 Views
14 Pages

Association Between Follistatin and PAI-1 Levels in MASLD Subjects Undergoing a Plant-Based Dietary Intervention

  • Nicole Cerabino,
  • Caterina Bonfiglio,
  • Martina Di Chito,
  • Rosanna Donvito,
  • Francesco Pio Mongelli,
  • Pasqua Letizia Pesole,
  • Dolores Stabile,
  • Endrit Shahini,
  • Marianna Zappimbulso and
  • Giovanni De Pergola
  • + 2 authors

26 June 2025

Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a chronic liver condition intricately linked to systemic metabolic impairments. Among the molecular mediators implicated in its pathogenesis, follistatin and plasminogen...

  • Article
  • Open Access
13 Citations
4,636 Views
21 Pages

Vitronectin and Its Interaction with PAI-1 Suggests a Functional Link to Vascular Changes in AMD Pathobiology

  • Fabiola Biasella,
  • Tobias Strunz,
  • Christina Kiel,
  • on behalf of the International AMD Genomics Consortium (IAMDGC),
  • Bernhard H. F. Weber and
  • Ulrike Friedrich

27 May 2022

The pathogenesis of age-related macular degeneration (AMD), a frequent disorder of the central retina, is incompletely understood. Genome-wide association studies (GWAS) suggest a strong contribution of genomic variation in AMD susceptibility. Nevert...

  • Article
  • Open Access
11 Citations
4,577 Views
12 Pages

Association of Plasminogen Activator Inhibitor-1 (PAI-1) Gene Polymorphisms with Osteoporotic Vertebral Compression Fractures (OVCFs) in Postmenopausal Women

  • Jung Oh Kim,
  • Soo Hong Han,
  • Yeon Ho Lee,
  • Tae Keun Ahn,
  • Jae Joon Lim,
  • Young Sun Chung,
  • Dong Eun Shin,
  • Woo Sik Lee,
  • In Bo Han and
  • Nam Keun Kim

9 December 2016

Osteoporosis and osteoporotic fractures are strongly associated with mortality and morbidity, both in developing and developed countries. Menopause accelerates bone loss due to estrogen deficiency and age-related linear bone loss. We investigated pla...

  • Article
  • Open Access
2 Citations
1,313 Views
20 Pages

A diet low in fermentable oligo-, di-, and monosaccharides and polyols (FODMAP) is an established treatment for irritable bowel syndrome (IBS). The starch- and sucrose-reduced diet (SSRD) is a newer, promising diet. Nutrients influence the production...

  • Article
  • Open Access
9 Citations
2,999 Views
13 Pages

28 November 2020

The most common type of cardiovascular disease is coronary artery disease (CAD), in which a plaque builds up inside the coronary arteries that can lead to a complete blockage of blood flow to the heart, resulting in a heart attack. The CAD may be aff...

  • Article
  • Open Access
1 Citations
1,619 Views
20 Pages

Hepatic AhR Activation by TCDD Induces Obesity and Steatosis via Hepatic Plasminogen Activator Inhibitor-1 (PAI-1)

  • Seung Jun Oh,
  • Suyeol Im,
  • Sora Kang,
  • Aden Geonhee Lee,
  • Byung Cheol Lee and
  • Youngmi Kim Pak

30 August 2025

Exposure to persistent organic pollutants such as 2,3,7,8-tetrachlorodibenzodioxin (TCDD) increases metabolic disorder risk. In this study, we show that a single intraperitoneal injection of TCDD (10 μg/kg) in C57BL/6J mice induced body weight gai...

  • Review
  • Open Access
699 Views
5 Pages

Cell Phenotype Determines PAI-1 Antiproliferative Effect—Suppressed Proliferation of the Lung Cancer but Not Prostate Cancer Cells

  • Joanna Chorostowska-Wynimko,
  • Marta Kędzior,
  • Radosław Struniawski,
  • Paulina Jaguś,
  • Ewa Skrzypczak-Jankun and
  • Jerzy Jankun

22 June 2010

Introduction: Plasminogen inhibitor activator type 1 (PAI-1) is an important regulator of tumor growth and metastasis formation acting directly via specific urokinase complexing or indirectly due to its affinity to vitronectin. We have shown previous...

  • Article
  • Open Access
22 Citations
4,543 Views
25 Pages

Adipocyte-Derived Leptin Promotes PAI-1-Mediated Breast Cancer Metastasis in a STAT3/miR-34a Dependent Manner

  • Si-Jing Li,
  • Xiao-Hui Wei,
  • Xiao-Man Zhan,
  • Jin-Yong He,
  • Yu-Qi Zeng,
  • Xue-Mei Tian,
  • Sheng-Tao Yuan and
  • Li Sun

21 December 2020

The crosstalk between cancer cells and adipocytes is critical for breast cancer progression. However, the molecular mechanisms underlying these interactions have not been fully characterized. In the present study, plasminogen activator inhibitor-1 (P...

  • Article
  • Open Access
13 Citations
4,311 Views
12 Pages

Plasminogen Activator Inhibitor-1 (PAI-1) Gene Polymorphisms Associated with Cardiovascular Risk Factors Involved in Cerebral Venous Sinus Thrombosis

  • Anca Elena Gogu,
  • Andrei Gheorghe Motoc,
  • Alina Zorina Stroe,
  • Any Docu Axelerad,
  • Daniel Docu Axelerad,
  • Ligia Petrica and
  • Dragos Catalin Jianu

23 April 2021

Cerebral venous sinus thrombosis (CVST), accounting for less than 1% of stroke cases, is characterized by various causes, heterogeneous clinical presentation and different outcome. The plasminogen activator inhibitor-1 (PAI-1) gene polymorphisms has...

  • Article
  • Open Access
7 Citations
1,451 Views
6 Pages

Influence of PAI-1 Gene Promoter-675 (4G/5G) Polymorphism on Fibrinolytic Activity After Cardiac Surgery Employing Cardiopulmonary Bypass

  • Agnese Ozolina,
  • Eva Strike,
  • Inta Jaunalksne,
  • Jelena Serova,
  • Tatjana Romanova,
  • Liene Nikitina Zake,
  • Olegs Sabelnikovs and
  • Indulis Vanags

4 November 2012

Background and Objective. The plasminogen activator inhibitor type-1 (PAI-1) gene promoter contains 675 (4G/5G) polymorphism. The aim of this study was evaluate the effect of the PAI-1 promoter-675 (4G/5G) polymorphism on the concentrations of PAI-1...

  • Article
  • Open Access
2 Citations
2,209 Views
16 Pages

Dioxin-Induced PAI-1 Expression: A Novel Pathway to Pancreatic β-Cell Failure in Type 2 Diabetes

  • Suyeol Im,
  • Sora Kang,
  • Woo Jung Son,
  • Minuk Son,
  • Seung Jun Oh,
  • Hye Ji Yoon and
  • Youngmi Kim Pak

7 November 2024

Exposure to environment-polluting chemicals (EPCs), which are ligands of the aryl hydrocarbon receptor (AhR), is associated with the development of type 2 diabetes (T2D). This study explores the mechanisms by which AhR ligands contribute to β-ce...

  • Article
  • Open Access
18 Citations
4,283 Views
14 Pages

Eupatilin Ameliorates Hepatic Fibrosis and Hepatic Stellate Cell Activation by Suppressing β-catenin/PAI-1 Pathway

  • Jinyuan Hu,
  • Yuanyuan Liu,
  • Zheng Pan,
  • Xuekuan Huang,
  • Jianwei Wang,
  • Wenfu Cao and
  • Zhiwei Chen

The activation of hepatic stellate cells (HSCs) has proved to be pivotal in hepatic fibrosis. Therefore, the suppression of HSC activation is an effective anti-fibrotic strategy. Although studies have indicated that eupatilin, a bioactive flavone fou...

  • Article
  • Open Access
24 Citations
9,563 Views
31 Pages

Elevated Cytokines, Thrombin and PAI-1 in Severe HCPS Patients Due to Sin Nombre Virus

  • Virginie Bondu,
  • Ron Schrader,
  • Mary Ann Gawinowicz,
  • Paul McGuire,
  • Daniel A. Lawrence,
  • Brian Hjelle and
  • Tione Buranda

10 February 2015

Sin Nombre Hantavirus (SNV, Bunyaviridae Hantavirus) is a Category A pathogen that causes Hantavirus Cardiopulmonary Syndrome (HCPS) with case fatality ratios generally ranging from 30% to 50%. HCPS is characterized by vascular leakage due to dysregu...

  • Article
  • Open Access
4 Citations
3,148 Views
20 Pages

Novel Function of Cancer Stem Cell Marker ALDH1A3 in Glioblastoma: Pro-Angiogenesis through Paracrine PAI-1 and IL-8

  • Zhen Chen,
  • Rainer Will,
  • Su Na Kim,
  • Maike Anna Busch,
  • Nicole Dünker,
  • Philipp Dammann,
  • Ulrich Sure and
  • Yuan Zhu

4 September 2023

Hyper-angiogenesis is a typical feature of glioblastoma (GBM), the most aggressive brain tumor. We have reported the expression of aldehyde dehydrogenase 1A3 (ALDH1A3) in proliferating vasculature in GBM patients. We hypothesized that ALDH1A3 may act...

  • Review
  • Open Access
13 Citations
5,089 Views
21 Pages

24 February 2023

Stressful events trigger a set of complex biological responses which follow a bell-shaped pattern. Low-stress conditions have been shown to elicit beneficial effects, notably on synaptic plasticity together with an increase in cognitive processes. In...

  • Review
  • Open Access
18 Citations
17,595 Views
14 Pages

2 March 2015

Plasminogen activator inhibitor-1 (PAI-1; SERPINE1) is a prominent member of the serine protease inhibitor superfamily (SERPIN) and a causative factor of multi-organ fibrosis as well as a key regulator of the tissue repair program. PAI-1 attenuates p...

  • Article
  • Open Access
5 Citations
2,772 Views
23 Pages

Targeting the PAI-1 Mechanism with a Small Peptide Increases the Efficacy of Alteplase in a Rabbit Model of Chronic Empyema

  • Galina Florova,
  • Christian J. De Vera,
  • Rebekah L. Emerine,
  • René A. Girard,
  • Ali O. Azghani,
  • Krishna Sarva,
  • Jincy Jacob,
  • Danna E. Morris,
  • Mignote Chamiso and
  • Andrey A. Komissarov
  • + 1 author

The incidence of empyema is increasing and associated with a mortality rate of 20% in patients older than 65 years. Since 30% of patients with advanced empyema have contraindications to surgical treatment, novel, low-dose, pharmacological treatments...

  • Article
  • Open Access
7 Citations
3,805 Views
19 Pages

19 April 2022

Irritable bowel syndrome (IBS) is characterized by gastrointestinal symptoms. Overweight and increased risk of metabolic syndromes/diabetes are observed in IBS, conditions associated with plasminogen activator inhibitor-1 (PAI-1) and visfatin. The ai...

  • Communication
  • Open Access
3 Citations
2,943 Views
11 Pages

SERPINE1 DNA Methylation Levels Quantified in Blood Cells at Five Years of Age Are Associated with Adiposity and Plasma PAI-1 Levels at Five Years of Age

  • Amelie Taschereau,
  • Véronique Desgagné,
  • Sabrina Faleschini,
  • Renée Guérin,
  • Catherine Allard,
  • Patrice Perron,
  • Marie-France Hivert and
  • Luigi Bouchard

5 October 2022

Plasminogen activator inhibitor (PAI-1) expression has been associated with a higher risk of development of obesity. DNA methylation (DNAm) is an epigenetic mechanism regulating gene transcription and likely involved in the fetal programming of child...

  • Article
  • Open Access
42 Citations
8,309 Views
15 Pages

Up-Regulation of PAI-1 and Down-Regulation of uPA Are Involved in Suppression of Invasiveness and Motility of Hepatocellular Carcinoma Cells by a Natural Compound Berberine

  • Xuanbin Wang,
  • Ning Wang,
  • Hongliang Li,
  • Ming Liu,
  • Fengjun Cao,
  • Xianjun Yu,
  • Jingxuan Zhang,
  • Yan Tan,
  • Longchao Xiang and
  • Yibin Feng

Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related death and its prognosis remains poor due to the high risk of tumor recurrence and metastasis. Berberine (BBR) is a natural compound derived from some medicinal plants, and a...

  • Review
  • Open Access
69 Citations
12,621 Views
22 Pages

PAI-1, the Plasminogen System, and Skeletal Muscle

  • Fasih Ahmad Rahman and
  • Matthew Paul Krause

25 September 2020

The plasminogen system is a critical proteolytic system responsible for the remodeling of the extracellular matrix (ECM). The master regulator of the plasminogen system, plasminogen activator inhibitor-1 (PAI-1), has been implicated for its role in e...

  • Article
  • Open Access
23 Citations
5,092 Views
12 Pages

The interactions of cancer cells with neighboring non-malignant cells in the microenvironment play an important role for progressive neoplastic development and metastasis. Long-term direct co-culture of human MDA-MB-231cherry breast cancer cells with...

  • Article
  • Open Access
11 Citations
4,413 Views
16 Pages

Structural Insights into the Mechanism of a Nanobody That Stabilizes PAI-1 and Modulates Its Activity

  • Machteld Sillen,
  • Stephen D. Weeks,
  • Sergei V. Strelkov and
  • Paul J. Declerck

15 August 2020

Plasminogen activator inhibitor-1 (PAI-1) is the main physiological inhibitor of tissue-type (tPA) and urokinase-type (uPA) plasminogen activators (PAs). Apart from being critically involved in fibrinolysis and wound healing, emerging evidence indica...

  • Article
  • Open Access
1 Citations
1,991 Views
8 Pages

The Curious Role of PAI-1 in Severe Obstructive Sleep Apnea

  • Tea Friščić,
  • Edvard Galić,
  • Domagoj Vidović,
  • Petrana Brečić and
  • Igor Alfirević

Plasminogen activator inhibitor-1 (PAI-1) has a significant role in fibrinolysis, atherogenesis, cellular senescence, and chronic inflammation. OSA (obstructive sleep apnea) leads to increased PAI-1 levels and the development of cardiovascular diseas...

  • Review
  • Open Access
22 Citations
8,032 Views
23 Pages

Obstructive sleep apnea is a chronic and prevalent condition that is associated with endothelial dysfunction, atherosclerosis, and imposes excess overall cardiovascular risk and mortality. Despite its high prevalence and the susceptibility of CVD pat...

  • Article
  • Open Access
21 Citations
3,249 Views
22 Pages

7 September 2020

Two photoactivatable near infrared fluorescent proteins (NIR FPs) named “PAiRFP1” and “PAiRFP2” are formed by directed molecular evolution from Agp2, a bathy bacteriophytochrome of Agrobacterium tumefaciens C58. There are 15 a...

  • Review
  • Open Access
12 Citations
4,851 Views
32 Pages

Inflammation during the perioperative period of joint arthroplasty is a critical aspect of patient outcomes, influencing both the pathophysiology of pain and the healing process. This narrative review comprehensively evaluates the roles of specific c...

  • Communication
  • Open Access
6 Citations
3,100 Views
13 Pages

PAI-1 Overexpression in Valvular Interstitial Cells Contributes to Hypofibrinolysis in Aortic Stenosis

  • Magdalena Kopytek,
  • Michał Ząbczyk,
  • Piotr Mazur,
  • Anetta Undas and
  • Joanna Natorska

16 May 2023

Aortic stenosis (AS) is associated with hypofibrinolysis, but its mechanism is poorly understood. We investigated whether LDL cholesterol affects plasminogen activator inhibitor 1 (PAI-1) expression, which may contribute to hypofibrinolysis in AS. St...

  • Review
  • Open Access
62 Citations
11,368 Views
12 Pages

The TGF-β1/p53/PAI-1 Signaling Axis in Vascular Senescence: Role of Caveolin-1

  • Rohan Samarakoon,
  • Stephen P. Higgins,
  • Craig E. Higgins and
  • Paul J. Higgins

3 August 2019

Stress-induced premature cellular senescence is a significant factor in the onset of age-dependent disease in the cardiovascular system. Plasminogen activator inhibitor-1 (PAI-1), a major TGF-β1/p53 target gene and negative regulator of the plas...

  • Article
  • Open Access
9 Citations
4,455 Views
21 Pages

Thrombin Upregulates PAI-1 and Mesothelial–Mesenchymal Transition Through PAR-1 and Contributes to Tuberculous Pleural Fibrosis

  • Cheng-Ying Hsieh,
  • Joen-Rong Sheu,
  • Chih-Hao Yang,
  • Wei-Lin Chen,
  • Jie-Heng Tsai and
  • Chi-Li Chung

13 October 2019

Thrombin is an essential procoagulant and profibrotic mediator. However, its implication in tuberculous pleural effusion (TBPE) remains unknown. The effusion thrombin and plasminogen activator inhibitor-1 (PAI-1) levels were measured among transudati...

  • Article
  • Open Access
3 Citations
2,452 Views
6 Pages

4 September 2019

Background and Objectives: Plasminogen activator inhibitor-1 (PAI-1) is a fibrinolytic system enzyme whose role in various fibrinolytic processes is currently unknown. In clinical manifestations of pleural liquids of diverse etiology, various levels...

  • Article
  • Open Access
12 Citations
22,326 Views
16 Pages

3 November 2009

The high pay packages of U.S. CEOs have raised serious concerns about what would constitute a fair pay. Since the present economic models do not adequately address this fundamental question, we propose a new theory based on statistical mechanics and...

  • Article
  • Open Access
1 Citations
2,252 Views
19 Pages

This study examines whether market competition reduces managerial slack under downward-sticky CEO pay schemes, thus mitigating the potentially negative link between downward-sticky pay and shareholder’s value. Using data on the Korean product m...

  • Article
  • Open Access
15 Citations
8,650 Views
16 Pages

4 December 2024

Financial support for environmental causes is more urgent than ever before. Thus, understanding consumer willingness to pay (WTP) for tourism is vital for policymakers, businesses, and researchers. This bibliometric study examined the trend of resear...

  • Article
  • Open Access
5,419 Views
36 Pages

Insider Trading before Earnings News: The Role of Executive Pay Disparity

  • Ann-Ngoc Nguyen,
  • Viet Le,
  • Andros Gregoriou and
  • David Kernohan

We investigate how executive pay disparity affects insider profits around earnings news. Our findings reveal that high pay disparity is linked to higher abnormal returns from insider purchases before positive news, suggesting insiders exploit good ne...

  • Article
  • Open Access
17 Citations
4,179 Views
15 Pages

Atorvastatin Inhibits Endothelial PAI-1-Mediated Monocyte Migration and Alleviates Radiation-Induced Enteropathy

  • Seo Young Kwak,
  • Sunhoo Park,
  • Hyewon Kim,
  • Sun-Joo Lee,
  • Won-Suk Jang,
  • Min-Jung Kim,
  • SeungBum Lee,
  • Won Il Jang,
  • Ah Ra Kim and
  • Hyosun Jang
  • + 2 authors

12 February 2021

Intestinal injury is observed in cancer patients after radiotherapy and in individuals exposed to radiation after a nuclear accident. Radiation disrupts normal vascular homeostasis in the gastrointestinal system by inducing endothelial damage and sen...

  • Article
  • Open Access
1 Citations
4,801 Views
11 Pages

Willingness to Pay for COVID-19 Vaccines in Japan

  • Takeshi Yoda,
  • Nagisa Iwasaki and
  • Hironobu Katsuyama

More than 80% of the Japanese population had received the coronavirus disease 2019 (COVID-19) vaccination by the end of April 2023; however, this vaccination rate continues to decline along with the need for booster shots. Further, the vaccines may n...

  • Review
  • Open Access
134 Citations
2,207 Views
10 Pages

Understanding the Global Measurement of Willingness to Pay in Health

  • Jean A. McDougall,
  • Wesley E. Furnback,
  • Bruce C. M. Wang and
  • Jörg Mahlich

Objective: To understand the different methodologies used to elicit willingness to pay for health and the value of a statistical life year through surveys. Methodology: A systematic review of the literature was undertaken to identify studies using su...

  • Article
  • Open Access
4 Citations
3,656 Views
20 Pages

6 October 2022

Pay-for-performance is important in procuring Public–Private Partnership projects to which existing research has not paid enough attention. We took 884 ecological construction and environmental protection PPP projects (eco-environmental PPPs) a...

  • Article
  • Open Access
2,782 Views
25 Pages

Insider Trading and CEO Pay-Gap Induced Turnover

  • Viet Le,
  • Ann-Ngoc Nguyen,
  • Andros Gregoriou and
  • William Forbes

We explore how insider trading returns, disparities in executive pay, and CEO turnover are interrelated. Our findings reveal both independent and interactive effects for insider trading returns, the CEO pay gap, and the likelihood of CEO turnover. Fi...

  • Article
  • Open Access
3,442 Views
15 Pages

Evolution of “Pay-It-Forward” in the Presence of the Temptation to Free-Ride

  • Satoshi Uchida,
  • Tatsuya Sasaki,
  • Hitoshi Yamamoto and
  • Isamu Okada

25 April 2024

“Paying it forward” is a behavior in which people help someone else because they were helped in the past. Although experimental evidence exists that indicates that real human beings often “pay-it-forward” even in the face of f...

of 169